How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD
|
|
- Silas Gregory
- 6 years ago
- Views:
Transcription
1 Improving care through shared knowledge How Does CCNC s Model Align with Value Based Payments? Lead Community Pharmacy Coordinator CCNC V.P. Moose Pharmacy Joe Moose, PharmD
2 $100 Total Healthcare Spend $10 Pharmacy Spend Non-pharmacy Health Care Spend $90
3 ( our community pharmacy experience) Dilemma: How to Scale Team-Based Medication Optimization Efforts? >32,000 Individuals received CCNC Transitional Care Support in 2015
4 Breaking Out of the Bubble ( our Policy Experience trying to Sell Community Pharmacy ) Care Team-Based extremely important Care Team focus less important
5 The Opportunity: In Health Reform Terms
6 Opportunity Knocks CCNC Enrollees with total Enrollees on Enrollees on Enrollees on Medication CCNC Enrollees medical cost > $10,000 CCNC Priority list TC Priority list Management Priority list Total number of members 1,348, ,529 17, ,241 6,377 Total medical cost $ 4,078 $ 27,527 $ 23,813 $ 18,215 $ 25,345 # of Inpatient visits Inpatient costs $ 369 $ 3,464 $ 5,337 $ 2,924 $ 6,456 # of mental health inpatient vi ED visits ED cost $ 178 $ 745 $ 1,262 $ 816 $ 1,657 Outpatient visits Mental health outpatient visits PCP visits Pharmacy visits Pharmacy costs (Pre Rebate) $ 721 $ 5,177 $ 3,342 $ 4,298 $ 6,183
7 It s Not Just About Star Ratings The reality of what is coming... or what may already be here Single = ACE-I Prescribed and Taken Home Run = BP < 140/90 Grand Slam = Patient Hospitalization Avoided
8 Refocusing on what matters Documenting what you did to get paid. Sharing what you did to help others care for your patient. Sharing Patient Aspirations Sharing what you found to aid in care delivery. Sharing what you plan to do next with the patients so others are aware.
9 What Does CPESN NC look Like?
10 Community Pharmacy Enhanced Services Network Enhanced Pharmacy Services - Services that transcend conventional requirements of an outpatient pharmacy program contract that are focused on improving clinical and global patient outcomes Examples include, but are not limited to: In-home delivery with patient status review medication synchronization with clinical review, Adherence packaging with patient coaching; and Care management services.
11 CPESN Distribution
12 Types of Enhanced Services 24 Hour Emergency Services Adherence Packaging Collection of Vital Signs Compounding Comprehensive Medication Review Home Delivery Home Visits Long-Acting Injections Med Synchronization Program Multi-Lingual Capability Naloxone Dispensing Nutritional counseling Point of Care Testing Smoking Cessation Standardized Assessments (PHQ-9) Disease State Management Programs
13 The Collaboration Card Moose Midland Pharmacy (704) Moose Pharmacy Mount Pleasant (704) (704) Moose Professional Pharmacy (704) Akers Pharmacy (910) TAS Drug (910) Realo Discount Drugs (704) Keever Pharmacy (704) CareFirst Specialty Pharmacy (704) Dilworth Drug (704) Rx Clinic Pharmacy The Pharmacy Locator Application 24 Hour Emergency Service/On Call (Dispensing) X X 24 Hour Emergency Service/On Call (Non-Dispensing) X X X X X X X Adherence Packaging X X X X X X X X X X Clozapine Dispensing and Monitoring X X X X X X X X Collection of Vital Signs X X X X X X X X X Compounding (Non-Sterile) X X X X X X X X X Compounding (Sterile) Comprehensive Medication Review X X X X X X X X X X DME Billing (Medicare and Medicaid) X X X X X X X Home Delivery (Free) X X X X X X X X X X Home Delivery (Fee Applies) X Home Visits X X X X X X X X X In Depth Counseling/Couching X X X X X X X X X Long-Acting Injections X X X X Med Synchronization Program X X X X X X X X X X Multi-Lingual Capability X X X X X X Naloxone Dispensing X X X X X X Nutritional Counseling X X X X X X X
14 We Must Determine Impactable Risk To prove a ROI to the payer Determine which patients are impacting the metrics of the payer Determine pharmacy activities that optimize medical benefits Determine how to enhance referral patterns to those that can do something about the problems
15 ONC National Meeting, January 24, 2014
16
17 Targeting Strategy CCNC Goals: 1) $30M in Savings 2) Increased Quality 3) Integration with Medical Home Care Management Structures Attributed Patients with Continuous Eligibility* Attributed Patients with DTP Declaration** Attributed Patients with CMR Received at CPESN Pharmacy*** (n = 27,252) (n = 2,973) (n = 409) Total Health Care Cost $6,717 (SD: $18,529) $20,678 (SD: $31,556) $25,649 (SD: $36,655) Preventable Health Care Cost $5,802 (SD: $15,341) $16,284 (SD: $21,570) $19,908 (SD: $24,383) Impactable Cost $258 (SD: $783) $804 (SD: $1,578) $1,172 (SD: $1,952) Number of ED visits 1.3 (SD: 2.7) 3.1 (SD: 5.4) 4.7 (SD: 6.6) Number of IP visits 0.2 (SD: 0.7) 0.9 (SD: 1.7) 1.0 (SD: 1.8) Global Risk Score 59.4 (SD: 13.8) 73.4 (SD: 10.8) 79.3 (SD: 8.0) * Patients are required to have continuous eligibility to Medicaid from 7/1/2014 to 6/30/2015 ** Patients had at least one DTP declaration in the 12 months period from 7/1/2014 to 6/30/2015 *** Patients had received Comprehensive Medication Review (CMR) in the past 120 days from 3/1/2015 to 6/30/3015
18 Targeting Strategy
19 The Opportunity: In Economic Terms to Medical Benefit
20 The Opportunity: In Economic Terms to Pharmacy Typical Referred Patient 10 Rx/Pt/Month Profit per Rx ~$10 How it Breaks Down ~ pts/day/referred to NC CPESN $1200/pt/yr X 200 pts = $240,000 in annual net profit per day
21 The Big Picture Increase, Develop and Sustain High Performing Networks of Pharmacies that provide enhanced services offerings Create Marketplace Presence of CPESN Networks Create Marketplace Dependency on CPESN Networks Facilitate local value propositions to other care team members to establish margin positive referral patterns Create care team dependency on clinical activities performed by community pharmacies to mitigate against risk narrow networking or reimbursement reductions on product distribution Establish Relationships and Reimbursement models with Medical Benefit side of payer infrastructure
22 The Value Proposition at the End of the Day What are patients, employers, taxpayers paying for? Some expenditures are investments, others are the result of lack of investment
23 What s driving this? It s all about pivoting toward payers & alternative primary care providers Desire to not be dependent on PBM s $1,000,000,000,000 CMS Quadruple AIM
24 ( our community pharmacy experience) Wake Up Call #1 I worry that [these pharmacies] we rely on for specialized services for our challenging patients are going to go out of business as their reimbursement continues to fall -Practicing Physician (and Medical Director)
25
26 Contact Information Joe Moose, PharmD VP, Moose Pharmacy Lead Community Pharmacy Coordinator, Community Care of North Carolina Moose_Pharmacy
Mutual and CCNC: What s the Difference?
Mutual and CCNC: What s the Difference? Objectives Review the history and current status of the CMMI grant Discuss the transition from CCNC to CPESN and how Mutual fits in Discuss how local networks (Mutual
More informationChallenges in High Dollar Drugs. Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare
Challenges in High Dollar Drugs Suzanne Francart, PharmD, BCPS Manager Infusion Services & Medication Assistance Program UNC HealthCare Disclosure I have no relevant conflicts of interest to disclose Learning
More informationFlorida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2016 through September 30, 2016
Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarter July 1, through September 30, Report to the Florida Legislature March 2018 [This page intentionally left blank.] Table
More informationShifting the Self-Pay Patient Paradigm: The Economic Management of the Patient Responsibility
Shifting the Self-Pay Patient Paradigm: The Economic Management of the Patient Responsibility Gregory M. Snow March 15, 2013 Agenda Healthcare Reform» Overview of Key Mandates Shifting the Paradigm» Impacts
More informationTHIRD-PARTY PHARMACY RECONCILIATION
THIRD-PARTY PHARMACY RECONCILIATION Billy Caster Sales Solution Expert Inmar Healthcare Network Jon Brumbaugh Sr. Manager, Product Inmar Healthcare Network Session Description A discussion and presentation
More informationDisease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry
Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry Jeffrey A. Bourret, M.S., R.Ph., FASHP Senior Director, Managed Markets Healthcare Systems Marketing
More informationSpecialty Pharmacy: A Key to Organizational Success in Population Health Management
Specialty Pharmacy: A Key to Organizational Success in Population Health Management Scott Knoer, MS, PharmD, FASHP Chief Pharmacy Officer, Cleveland Clinic Steve Rough, MS, RPh, FASHP Director of Pharmacy,
More informationFlorida Medicaid Prescribed Drug Service Spending Control Initiatives
Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarters January 1, through March 31, and April 1, through June 30, Report to the Florida Legislature April 2018 [This page
More informationThe U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use. Presented by Daniel Tomaszewski Pharmd, PhD
The U.S. Healthcare System: How Pharmacy Benefit Managers Impact Prescription Drug Use Presented by Daniel Tomaszewski Pharmd, PhD 1 Medical Vs. Pharmacy Coverage Medical Insurance Managed by an Insurance
More informationFrequently Asked Questions
Frequently Asked Questions Q. What is an Open Delivery System? A. An Open Delivery System provides access to a host of affiliated providers with admitting privileges at various HAP-contracted hospitals
More information340B Drug Pricing Program
340B Drug Pricing Program Mary Stepanyan, PharmD Candidate 2018 University of Southern California, School of Pharmacy Pro Pharma Pharmaceutical Consultants Under the preceptorship of Dr. Craig Stern WHY
More informationThe Health Insurance Market in Virginia. Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017
The Health Insurance Market in Virginia Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017 Anthem Inc. at a Glance Broad geographic footprint and customer base ` BCBS plans
More informationMedicaid Prescribed Drug Program Spending Control Initiatives. For the Quarter April 1, 2014 through June 30, 2014
Medicaid Prescribed Drug Program Spending Control Initiatives For the Quarter April 1, 2014 through June 30, 2014 Report to the Florida Legislature January 2015 Table of Contents Purpose of Report... 1
More informationHow ACO s Can Impact Contracting A Real World Example. Mike Medel Pharm D, MBA Banner Health
How ACO s Can Impact Contracting A Real World Example Mike Medel Pharm D, MBA Banner Health Agenda Banner Pharmacy Services Introduction Accountable Care Organization Summary Basic Constructs of ACO Partnership
More informationCommon Managed Care Terms & Definitions
Contact Us: Email: info@emedbiz.com Phone: 561-430-2090 Fax: 561-430-2091 Website: www.emedbiz.com Common Managed Care Terms & Definitions Balance billing: The practice of billing a patient for the amount
More informationGlossary of Terms (Terms are listed in Alphabetical Order)
Glossary of Terms (Terms are listed in Alphabetical Order) Access Access refers to the availability and location of pharmacies that participate in the network that serves your pharmacy benefit plan. Acute
More informationCody Wiberg, Pharm.D., M.S., R.Ph. Executive Director Minnesota Board of Pharmacy
Cody Wiberg, Pharm.D., M.S., R.Ph. Executive Director Minnesota Board of Pharmacy UNITED STATES MILITARY CANADIAN MILITARY Pharmacy Preferred Providers as Selected by Drug Manufacturers and Third
More informationFederal Spending on Brand Pharmaceuticals. April 2011
Federal Spending on Brand Pharmaceuticals April 2011 Summary Avalere Health estimates that manufacturers of brand-name prescription drugs will receive about $777 billion in revenues from the sales of outpatient
More informationPresentation to the IOM Committee on Core Metrics Tom Williams, Dr PH, President & CEO, IHA January 7, 2014, Irvine, California
Presentation to the IOM Committee on Core Metrics Tom Williams, Dr PH, President & CEO, IHA January 7, 2014, Irvine, California Organization: California multi-sector healthcare leadership group Mission:
More informationMEDICARE ADVANTAGE MA Plans. to $28 per month 46% HOW HEALTH SYSTEMS CAN THRIVE WITH. Developing Your Medicare Advantage Strategy PRODUCT
HOW HEALTH SYSTEMS CAN THRIVE WITH MEDICARE ADVANTAGE The 2019 Medicare Advantage (MA) plan year began on January 1st and once again more Americans enrolled in MA plans than the year before. Fueled by
More informationClinically Integrated Networks and Population Health The next chapter in healthcare
Clinically Integrated Networks and Population Health The next chapter in healthcare M A T T H E W M A T U S I A K, D H S C, F R I P H ( UK) M T ( A S C P ) Health System Challenges While the Uninsured
More informationSession 75 OF, Advantages & Challenges for Provider Led Health Plans. Moderator: LuCretia Leola Hydell, ASA, MAAA
Session 75 OF, Advantages & Challenges for Provider Led Health Plans Moderator: LuCretia Leola Hydell, ASA, MAAA Presenters: Jerry Clark, MD, FACP Josh Martin Mark Rishell SOA Antitrust Disclaimer SOA
More informationAFFORDABILITY REVIEW. Mysteries of the Medical Loss Ratio
AFFORDABILITY REVIEW Mysteries of the Medical Loss Ratio NANCY DJORDJEVIC DIRECTOR, HEALTHCARE ANALYTICS APRIL 2016 WHO IS GORMAN HEALTH GROUP? Gorman Health Group is the leading solutions and consulting
More informationAugust 4, The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C.
August 4, 2009 The Honorable Charles Rangel, Chairman Committee on Ways and Means United States House of Representatives Washington, D.C. 20515 The Honorable Henry A. Waxman, Chairman Committee on Energy
More informationEvidence-Based Program Reimbursement Strategies. Timothy P. McNeill, RN, MPH
Evidence-Based Program Reimbursement Strategies Timothy P. McNeill, RN, MPH 1 Medicare & Value Based Purchasing 2 Medicare Advantage Changes 3 DSMT Requirements 4 CDSME Tip Sheet Opportunities for EB Programs
More informationMedicare payment policy and its impact on program spending
Medicare payment policy and its impact on program spending James E. Mathews, Ph.D. Deputy Director, Medicare Payment Advisory Commission February 8, 2013 Outline of today s presentation Brief background
More informationSteve Liles, PharmD Senior Director, Value Based Purchasing Magellan Medicaid Administration
Medicaid Drug Rebates Steve Liles, PharmD Senior Director, Value Based Purchasing Magellan Medicaid Administration Medicaid Drug Rebates History of Medicaid Drug Rebates and Preferred Drug Lists Affordable
More informationFlorida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter April 1, 2016 through June 30, 2016
Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarter April 1, through June 30, Report to the Florida Legislature December 2017 [This page intentionally left blank.] Table
More informationLindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy
Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy Under the Preceptorship of Dr. Craig Stern Pro Pharma Pharmaceutical Consultants, Inc. September 11, 2015 S OBJECTIVES
More informationDIR fees are knocking down pharmacy profits
16 America s PHARMACIST November 2016 DIR fees are knocking down pharmacy profits by Bruce A. Semingson, Pharmacist In 2016, retail pharmacy will pay between $360 million and $2.16 billion in direct and
More information114.6 CMR: DIVISION OF HEALTH CARE FINANCE AND POLICY MEDICAL SECURITY BUREAU
114.6 CMR 14.00: HEALTH SAFETY NET PAYMENTS AND FUNDING Section 14.01: General Provisions 14.02: Definitions 14.03: Sources and Uses of Funds 14.04: Total Hospital Assessment Liability to the Health Safety
More informationCBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting
CBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting Avalere Health An Inovalon Company February 28, 2017 Growth in Drug Costs Relative to
More informationGLOSSARY OF USEFUL HEALTH INSURANCE TERMS
Data Decisions Delivery Directing Comprehensive TA: From Systems to Sustainability GLOSSARY OF USEFUL HEALTH INSURANCE TERMS This glossary is adapted from an array of resources to improve the health insurance
More informationMedicare Part D: Better understanding the nuances of the prescription drug benefit
Medicare Part D: Better understanding the nuances of the prescription drug benefit Rajul A. Patel, Pharm.D, Ph.D. TJL School of Pharmacy & Health Sciences University of the Pacific July 26 th, 2018 Today
More informationOverview of Coverage of Drugs Under the Medicaid Medical Benefit
Overview of Coverage of Drugs Under the Medicaid Medical Benefit June 4, 2008 Amanda Bartelme Avalere Health LLC Avalere Health LLC The intersection of business strategy and public policy Medical vs. Pharmacy
More informationSelectHealth Prescriptions
SelectHealth Prescriptions pharmacy benefit management program SM SelectHealth Prescriptions is a full-service Pharmacy Benefit Manager (PBM) that offers transparent pricing, clinically based programs,
More informationIowa Medicaid Synopsis of Managed Medicaid Request for Proposal
Iowa Medicaid Synopsis of Managed Medicaid Request for Proposal The following information provides summary information of key aspects of the Iowa Medicaid Request For Proposal SOW for Capitated Managed
More informationBlue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy
Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - In this Section there are references unique to Blue Essentials, Blue Advantage HMO and Blue Premier. These network specific
More informationOpportunities on the Horizon. CCWJC/CCPN Provider Meeting Update November 2 nd, 2017
Opportunities on the Horizon CCWJC/CCPN Provider Meeting Update November 2 nd, 2017 CCPN is physician-led and will: Increase quality and efficiency of health care Support independent, rural and/or small
More informationManufacturer Patient Support Initiatives: Current Practices and Recent Challenges. Andrew Ruskin Morgan Lewis
Intersecting Worlds of Drug, Device, Biologics and Health Law AHLA/FDLI May 22, 2012 Manufacturer Patient Support Initiatives: Current Practices and Recent Challenges by Andrew Ruskin Morgan Lewis The
More informationTotal Cost of Care in Oregon s Commercial Market. March 2, 2017
Total Cost of Care in Oregon s Commercial Market March 2, 2017 Background: Q Corp About us Independent, nonprofit organization Neutral, multistakeholder collaboration Celebrated our 16 th anniversary Mission
More informationWorkers Compensation Board Pharmacy Benefit Plan
1.0 Introduction Workers Compensation Board Pharmacy Benefit Plan Options for pharmaceutical care have greatly expanded over the past several years. New pharmaceuticals and pharmaceutical treatment modalities
More informationTrekking Towards Value Based Payments
Trekking Towards Value Based Payments October 5, 07 Melody Anthony, MS Deputy State Medicaid Director Agenda Overview SoonerCare s Beginning Current Patient Centered Medical Home Delivery System CPC Classic
More informationAPPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1
APPENDIX B: VENDOR DRUG PROGRAM TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 APRIL 2018 TEXAS MEDICAID PROVIDER PROCEDURES MANUAL: VOL. 1 APRIL 2018 APPENDIX B: VENDOR DRUG PROGRAM Table of Contents
More informationPrescription Drugs Spending Distribution and Cost Drivers. Steve Kappel January 25, 2007
Prescription Drugs Spending Distribution and Cost Drivers Steve Kappel January 25, 2007 Introduction Why Focus on Drugs? Compared to other health care spending: Even faster annual growth Higher reliance
More informationPrescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017
Prescription Drug Pricing and Community Pharmacy NALEO Legislative Summit on Health October 21, 2017 Ronna Hauser, PharmD VP Pharmacy Affairs The strength of our numbers NCPA represents America's 22,000+
More informationService Participating Providers: Non-participating Providers:
Bend Chamber of Commerce Provider Network: SmartChoice Medical Benefit Summary SmartChoice HSA 3000_50+Rx S2 Annual Deductible Per Person, Per Calendar Year Per Family, Per Calendar Year Participating
More information2019 RETIREE MEDICAL PLAN Information Session
2019 RETIREE MEDICAL PLAN Information Session Freedom, Journey & Retiree National Choice Freedom, Journey & Retiree National Choice Program Name U of M Retiree Plan with Group reblue SM Rx re Supplement
More informationPay for Performance & the Changing Landscape for Pharmacy: A Panel Discussion
Pay for Performance & the Changing Landscape for Pharmacy: A Panel Discussion Panelists: Mark Conklin, Pharmacy Quality Solutions Alex Cruz, Healthfirst Crystal Lennartz, Health Mart Jesse McCullough,
More informationBERKELEY RESEARCH GROUP. Executive Summary
Executive Summary Within the U.S. healthcare system, the flow of dollars in the pharmaceutical marketplace is a complex process involving a variety of stakeholders and myriad rebates, discounts, and fees
More informationService Participating Providers: Non-participating Providers:
Bend Chamber of Commerce Provider Network: SmartChoice Medical Benefit Summary SmartChoice 3000+25-50_30 S2 Annual Deductible Per Person, Per Calendar Year Per Family, Per Calendar Year All Providers $3,000
More informationVALUE-BASED PAYMENTS, STAR RATINGS AND THE LESSONS OF MEDICARE ADVANTAGE. A Presentation to the 11 th Annual Value-Based Payment and P4P Summit
VALUE-BASED PAYMENTS, STAR RATINGS AND THE LESSONS OF MEDICARE ADVANTAGE A Presentation to the 11 th Annual Value-Based Payment and P4P Summit JOHN GORMAN EXECUTIVE CHAIRMAN FEBRUARY 19, 2016 CUT TO THE
More informationThe Management of Specialty Drugs: Opportunities and Challenges
The Management of Specialty Drugs: Opportunities and Challenges Scott Woods Senior Director, Policy PCMA Innovations X April 5, 2016 Specialty Drugs to be Half of Spend by 2018 Forecast PMPM Net Drug
More informationPresented by: Steven Flores. Prepared for: The Predictive Modeling Summit
Presented by: Steven Flores Prepared for: The Predictive Modeling Summit November 13, 2014 Disease Management Introduction A multidisciplinary, systematic approach to health care delivery that: Includes
More informationApril 8, 2019 VIA Electronic Filing:
April 8, 2019 VIA Electronic Filing: http://www.regulations.gov The Honorable Alex Azar Secretary Department of Health and Human Services 200 Independence Avenue SW, Room 600E Washington, D.C. 20201 Re:
More informationUnderstanding Pay For Performance and DIR Impact to Pharmacy Reimbursement
Understanding Pay For and DIR Impact to Pharmacy Reimbursement A Public Service Announcement brought to you by Melanie Maxwell, MHP Vice President RxSelect Pharmacy Services Please Don t Shoot the Messenger
More informationFlorida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter October 1, 2017 through December 31, 2017
Florida Medicaid Prescribed Drug Service Spending Control Initiatives For the Quarter October 1, through December 31, Report to the Florida Legislature September 2018 [This page intentionally left blank.]
More informationCompensation and Reimbursement
492 Pharmacy Management: Compensation and Reimbursement Positions Compensation and Reimbursement Revenue Cycle Compliance and Management (1710) To encourage pharmacists to serve as leaders in the development
More informationHow you are being measured by health plans, PBMs and accreditation organizations. December 2013
How you are being measured by health plans, PBMs and accreditation organizations December 2013 1 The U.S. health care system is rapidly moving to valuebased purchasing or value-driven healthcare Value
More informationDelivering Value for All Health Care Stakeholders. Larry Merlo President & Chief Executive Officer
Delivering Value for All Health Care Stakeholders Larry Merlo President & Chief Executive Officer Agenda Our Value Proposition Has Never Been Stronger We See Compelling Opportunities in a Robust Health
More informationOklahoma Health Care Authority
Oklahoma Health Care Authority It is very important that you provide your comments regarding the proposed rule change by the comment due date. Comments are directed to Oklahoma Health Care Authority (OHCA)
More informationMedicaid Prescribed Drug Program. Spending Control Initiatives
Medicaid Prescribed Drug Program Spending Control Initiatives For Quarters Ended September 30, December 31, Table of Contents Purpose of Report... 1 Executive Summary... 2 Pharmacy Appropriations and Spending
More informationFactors in Physician Practice Valuation. May 2017
Factors in Physician Practice Valuation May 2017 Factors in Physician Practice Valuation Physician practice owners considering a sale may not have experience assessing the value of their practices in terms
More informationManaging Specialty Pharmaceuticals: Balancing Access and Affordability
Managing Specialty Pharmaceuticals: Balancing Access and Affordability Commercial Health Plan Perspective The Health Industry Forum July 16, 2008 Presented by: Margaret M. (Peggy) Johnson, R.Ph. Vice President
More informationGrowth in an Evolving Health Care Market
Driving Enterprise Growth in an Evolving Health Care Market Larry Merlo President & Chief Executive Officer Agenda Our Compelling Value Proposition Evolving Health Care Market Creates Opportunities Strategic
More information10 Best Payer Contracting Practices for Presented By: Mr. Steve Selbst, CEO Healthcents Inc. November 7, 2018
10 Best Payer Contracting Practices for 2019 Presented By: Mr. Steve Selbst, CEO Healthcents Inc. November 7, 2018 Healthcents Services Payer contracts analysis and negotiations Healthcare Consulting Services
More informationThe 340B drug discount program was created in 1992
Proposed Rule Changes for 340B Programs: Overview and Impact Anthony Zappa, PharmD, MBA Specialty Healthcare Benefits Council The 340B drug discount program was created in 1992 as a means for certain nonprofit
More informationPharmacy Trend Management
Pharmacy Trend Management Strategies for Maximizing the Value of Your Pharmacy Spend Presenter's Name Presentation Date May 1, 2008 Today s speakers Bridget Eber, Pharm.D. Principal and National Pharmacy
More informationVia Electronic Submission (www.regulations.gov) January 16, 2018
Via Electronic Submission (www.regulations.gov) January 16, 2018 Ms. Seema Verma Administrator Centers for Medicare & Medicaid Services U.S. Department of Health and Human Services ATTN: CMS-4182-P 7500
More informationTotal Cost of Care in Oregon s Commercial Market. February 24, 2017
Total Cost of Care in Oregon s Commercial Market February 24, 2017 Background: Q Corp About us Independent, nonprofit organization Neutral, multistakeholder collaboration Celebrated our 16 th anniversary
More informationUnique PBM Capabilities
Gaining Lives With Our Unique PBM Capabilities Jon Roberts Executive Vice President & President, CVS/caremark Agenda Performance Highlights Pharmacy Trends and Cost Management Programs Well Positioned
More informationAccess, Quality & Transparency: The Forgotten Issues in the Healthcare Debate Presented at WCIF Benefits Summit April 19, 2017
Access, Quality & Transparency: The Forgotten Issues in the Healthcare Debate Presented at WCIF Benefits Summit April 19, 2017 What s happened? What s next? The ACA remains the Law of the Land for now!
More information2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:
2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754: Essentials Rx 6 (HMO), Essentials Rx 14 (HMO), Essentials Rx 15 (HMO), Essentials Rx 16 (HMO), Essentials Rx 19 (HMO),
More informationChapter 21. Pharmacy Services
Last Updated: 11/14/2018 1:52:00 PM Chapter 21 Pharmacy Services Definitions Compounded Prescription: A prescription prepared in accordance with Minnesota Rules 6800.3100. Dispensing Date: The actual date
More informationEstablish fair elmbursements
Needed PBM (Pharmacy BeneFit Manager] ReForms - for patients NOW O j.imit purpose nd scope Require price transparency Establish fair elmbursements PBMs started as third party admintsbalors simply chargingan
More informationPharmacy Benefit Managers Overview
Pharmacy Benefit Managers Overview A Presentation to the House Health Innovation Subcommittee Mary Alice Nye, Ph.D. Health and Human Services Staff Director, OPPAGA December 6, 2017 Pharmacy Benefit Managers
More informationRe: Medicare Prescription Drug Benefit Manual Draft Chapter 5
September 18, 2006 BY ELECTRONIC DELIVERY Cynthia Tudor, Ph.D. Director, Medicare Drug Benefit Group Centers for Medicare and Medicaid Services Department of Health and Human Services Mail Stop C4-13-01
More informationA Unique Vision of Care. Jefferies 2014 Global Healthcare Conference June 3, 2014
A Unique Vision of Care Jefferies 2014 Global Healthcare Conference June 3, 2014 Cautionary Statement The following schedules and statements made in this presentation constitute forward-looking statements
More informationPublic Employees Benefits Program Legislative Session Bill Tracking Updated: 3/27/2017
Public Employees Benefits Program Legislative Session Bill Tracking Updated: 3/27/2017 Bill Number & Description Impact to PEBP & Bill Status AB249 (BDR 38-858) Requires the State Plan for Medicaid and
More informationMeeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark
Meeting the Health Care Challenges of Tomorrow Jon Roberts Executive Vice President & President, CVS Caremark Agenda PBMs: Needed Now More Than Ever Performance Highlights How We Address Payors #1 Priority:
More informationOHSU Center for Evidence-based Policy Rhonda Anderson, RPh Director of Pharmacy National Conference of State Legislators San Diego, CA December 10,
OHSU Center for Evidence-based Policy Rhonda Anderson, RPh Director of Pharmacy National Conference of State Legislators San Diego, CA December 10, 2017 Today s Presentation Center for Evidence-based Policy
More informationPRACTICE TRANSFORMATION. Moving Towards A Future of Team Based Care. Michael A. Kolber, PhD, MD
PRACTICE TRANSFORMATION Moving Towards A Future of Team Based Care Michael A. Kolber, PhD, MD 1 2 Financial Disclosures: None Thomas Cole, The Voyage of Life: Childhood 4 Medicare Passed into Law 1965
More informationMATERIAL COVERED TODAY
MATERIAL COVERED TODAY This presentation has been designed to discuss compliance needs, proposed changes and best practices for covered entities in the 340B Drug Pricing Program This presentation should
More informationInnovations: Using a Clinical Pharmacist as a Vehicle for Successful P4P Outcomes
Innovations: Using a Clinical Pharmacist as a Vehicle for Successful P4P Outcomes Lisa Meland, B.S., PharmD. Helen Pervanas, R.Ph. WellPoint-WellPoint NextRx Overview Rising pharmacy trends Relationship
More information340B Drug Program Compliance: Focus on Disproportionate Hospitals
340B Drug Program Compliance: Focus on Disproportionate Hospitals Part II: 340B Drug Program Compliance: Pharmacy Operations and the DSH January 29, 2014 1 Faculty Stephen J. Weiser, JD, LLM Director 312-403-4284
More informationDeductible Per Calendar Year In-network Out-of-network
Provider Network: SmartChoice Medical Schedule of Benefits SmartChoice Bronze HSA 6650 Deductible Per Calendar Year In-network Out-of-network Individual/Family $6,650/$13,300 $10,000/$20,000 Out-of-Pocket
More informationGrowth and Success of Accountable Care Organizations (ACOs) in the US from Dennis Horrigan June 2016
Growth and Success of Accountable Care Organizations (ACOs) in the US from 2010-2016 Dennis Horrigan June 2016 Introducing Dennis Horrigan Dennis R. Horrigan President and Chief Executive Officer Catholic
More informationRewarding High Quality: Practical Models for Value- Based Physician Payment
Rewarding High Quality: Practical Models for Value- Based Physician Payment Introduction In its 2013 report, Moving Beyond Fee-for-Service, the Alliance of Community Health Plans (ACHP) addressed the increasing
More informationEXECUTIVE SUMMARY ENROLLMENT GROWS YET MARGINS DROP FOR OHIO S HEALTH INSURING CORPORATIONS. 970,000 Ohioans remained uninsured in 2014.
OHA exists to collaborate with member hospitals and health systems to ensure a healthy Ohio. February 2016 EXECUTIVE SUMMARY ENROLLMENT GROWS YET MARGINS DROP FOR OHIO S HEALTH INSURING CORPORATIONS In
More informationThe Impact of Adherence Quality Measures on the US Healthcare Marketplace
The Impact of Adherence Quality Measures on the US Healthcare Marketplace Samuel Stolpe, PharmD Associate Director, Quality Initiatives Pharmacy Quality Alliance Pharmacy Quality Alliance (PQA) Established
More informationSee Medical Benefit Summary See Medical Benefit Summary
Benefit Summary Outpatient Prescription Drug Products Illinois Plan MM Standard Drugs: 0/0/0 Your Co-payment and/or Co-insurance is determined by the tier to which the Prescription Drug List (PDL) Management
More information10 Best Practices For Payer Contracting: A Roadmap for Successful Negotiations
10 Best Practices For Payer Contracting: A Roadmap for Successful Negotiations Steve Selbst Healthcents, Inc. Speaker Disclosures Steve Selbst is employed by a business firm that provides services related
More information10 Best Practices For Payer Contracting:
10 Best Practices For Payer Contracting: A Roadmap for Successful Negotiations Steve Selbst Healthcents, Inc. 2016 NHIA Annual Conference & Exposition 1 Speaker Disclosures Steve Selbst is employed by
More informationPharmaceutical Management Commercial Plans
Pharmaceutical Management Commercial Plans 2015 Toll Free Contact Number: (888) 327-0671 Medical Management: (810) 733-9711 Visit our website at: MclarenHealthPlan.org Introduction Pharmaceutical Management
More informationSession 66 L, Value Based Approach for the Medicare Advantage Market. Presenters: Julia Friedman, FSA, MAAA Matthew Kranovich, FSA, MAAA
Session 66 L, Value Based Approach for the Medicare Advantage Market Presenters: Julia Friedman, FSA, MAAA Matthew Kranovich, FSA, MAAA SOA Antitrust Disclaimer SOA Presentation Disclaimer Value Based
More information10.1 Summary Prescription drug coverage for you and your eligible Dependents Three-tier Copayment plan Retail and maintenance programs
10.1 Summary Prescription drug coverage for you and your eligible Dependents Three-tier Copayment plan Retail and maintenance programs Through the Prescription Drug Plan, you and your eligible Dependents
More informationLAWS OF ALASKA AN ACT
LAWS OF ALASKA 01 Source CSHB 1(FIN) Chapter No. AN ACT Relating to workers' compensation fees for medical treatment and services; relating to workers' compensation regulations; and providing for an effective
More informationBENCHMARKING REPORT. Sponsored by PCCA
2017 BENCHMARKING REPORT Sponsored by PCCA NCPA Community Pharmacy Start-up Benchmarking Report, Sponsored by PCCA Project Director and Financial Editor Leon Michos, PhD NCPA Health Care Economist Project
More informationHow Medication Adherence and Outcomes Are Changing the Business Model
How Medication Adherence and Outcomes Are Changing the Business Model Laura Cranston Executive Director Todd Sega Manager, Payer Relations Lari Harding VP, Strategy & Growth Healthcare Network 3 Session
More informationJuly 23, Dear Mr. Slavitt:
Andy Slavitt Acting Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue, S.W., Room 445-G Washington, DC 20201 RE: Proposed Rule: RIN 0938-AS25 Medicaid
More information